Last reviewed · How we verify
NCT04385953
QStat in Trauma and Obstetric Hemorrhage
trial testing Quantra System in Blood Loss Massive in 22 participants. Completed in 1 August 2020.
1 July 2020
Quick facts
| Lead sponsor | HemoSonics LLC |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 22 |
| Start date | 10 December 2019 |
| Primary completion | 1 July 2020 |
| Estimated completion | 1 August 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Quantra System
Conditions studied
- Blood Loss Massive — all drugs for Blood Loss Massive →
- Trauma — all drugs for Trauma →
- Post Partum Hemorrhage — all drugs for Post Partum Hemorrhage →
Sponsor
HemoSonics LLC — full company profile →
Who can join
18 and older, any sex, with Blood Loss Massive or Trauma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the QStat Cartridge in trauma patients and obstetric patients with postpartum hemorrhage.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04385953
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Quantra System
Trials testing the same drug.
- NCT07447713 — Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients · not yet recruiting
- NCT06415760 — Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients · completed
- NCT05875987 — Evaluation of the Quantra QStat System in Obstetric Patients · completed
- NCT05426564 — Exploratory Assessment of the Quantra® System in Adult ECMO Patients · completed
- NCT04460664 — Coagulation Changes Associated With COVID-19 Infection · completed
Other HemoSonics LLC trials
Trials by the same sponsor.
- NCT07447713 — Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients · not yet recruiting
- NCT06255496 — QStat Cartridge in Obstetric Patients · completed
- NCT06415760 — Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients · completed
- NCT06025708 — Quantra QStat Sample Type Comparison · completed
- NCT05875987 — Evaluation of the Quantra QStat System in Obstetric Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04385953 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by HemoSonics LLC
- Last refreshed: 1 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04385953.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing